Sort
39,280 grants matching “leukemia”
Regulation and manipulation of the telomerase RNA component in hematopoiesis
$475,725Suneet Agarwal · Boston Children'S Hospital · R01 · FY2025 · DK
Regulation and manipulation of the telomerase RNA component in hematopoiesis
$475,725Suneet Agarwal · Boston Children'S Hospital · R01 · FY2023 · DK
RNAi Analysis and Screening for Study of Genes and Anti-Cancer Treatments
$475,663Natasha Caplen · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Pediatric Clinical Oncology Research Training Program
$475,607David G. Poplack · Baylor College Of Medicine · K12 · FY2011 · CA
Polygenic Risk Scores for Healthier African American Families
$475,567Cynthia A. Prows · Cincinnati Childrens Hosp Med Ctr · U01 · FY2023 · HG
Targeting TET1 signaling to treat acute myeloid leukemia
$475,560Jianjun Chen · Beckman Research Institute/City Of Hope · R01 · FY2018 · CA
Enhancing Doctor-Patient Communication
$475,556Stephanie J Lee · Fred Hutchinson Cancer Research Center · R01 · FY2006 · CA
Genetic analysis of mouse chromosome 11
$475,508Monica Jean Justice · Baylor College Of Medicine · R01 · FY2009 · CA
The role of Kmt2c/MLL3 in hematopoietic stem cell self-renewal, commitment and exhaustion
$475,499Jeffrey Alan Magee · Washington University · R01 · FY2024 · HL
The role of Kmt2c/MLL3 in hematopoietic stem cell self-renewal, commitment and exhaustion
$475,499Jeffrey Alan Magee · Washington University · R01 · FY2025 · HL
Regulation of Protein Synthesis in Leukemia Stem Cells
$475,420Stephen Shiu-Wah Chung · Ut Southwestern Medical Center · R37 · FY2025 · CA
Regulation of Protein Synthesis in Leukemia Stem Cells
$475,420Stephen Shiu-Wah Chung · Ut Southwestern Medical Center · R37 · FY2023 · CA
Identifying markers of abnormal neurocognitive trajectories during chemotherapy treatment of childhood acute lymphoblastic leukemia
$475,253Ellen Van Der Plas · Arkansas Children'S Hospital Res Inst · R37 · FY2022 · CA
Control of B cell Development by YY1
$475,202Michael L. Atchison · University Of Pennsylvania · R01 · FY2016 · AI
O-Glycosylation of Epidermal Growth Factor-like Motifs
$475,187Robert S. Haltiwanger · University Of Georgia · R01 · FY2020 · GM
Live Cell Imaging Confocal Microscope with Spectral Detector and Resonant Scanner
$475,138David Lagunoff · Univ Of Med/Dent Of Nj-Nj Medical School · S10 · FY2011 · RR
Metabolic control of normal and malignant hematopoiesis
$475,107Andrew Michael Intlekofer · Sloan-Kettering Inst Can Research · R37 · FY2023 · CA
Experimental Therapeutics
$475,056Max S. Wicha · University Of Michigan At Ann Arbor · P30 · FY2015 · CA
Dynamics of Tumor Stem Cells in Cancer Initiation, Therapy, and Resistance
$475,049Franziska Michor · Dana-Farber Cancer Inst · R01 · FY2012 · CA
Molecular Inhibition of Apoptosis Inhibitors
$474,997John C Reed · University Of California, San Diego · P01 · FY2012 · CA
Establishing CUX1 as a determinant of hematopoietic stem cell fate
$474,898Megan McNerney · University Of Chicago · R01 · FY2023 · HL
Establishing CUX1 as a determinant of hematopoietic stem cell fate
$474,898Megan McNerney · University Of Chicago · R01 · FY2025 · HL
NanoOptogenetic immunotherapy for B cell lymphoma
$474,840Gang Han · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · CA
The pathophysiology of type 1 versus type 2 mutant calreticulin-drivenmyeloproliferative neoplasms
$474,785Shannon Elisabeth Elf · University Of Chicago · R01 · FY2023 · HL
Clinical Transplantation Exploiting NK Cell Activity
$474,779Daniel J Weisdorf · University Of Minnesota · P01 · FY2014 · CA